Rhenman & Partners Asset Management AB raised its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 6,600.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 33,500 shares of the medical research company’s stock after purchasing an additional 33,000 shares during […]